Stocktoria
Entrada Therapeutics, Inc. TRDA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-29
Entrada Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,693,867 | $24.1M | 4.09% |
| MILLENNIUM MANAGEMENT LLC | 763,959 | $5.6M | 1.85% |
| AQR CAPITAL MANAGEMENT LLC | 699,537 | $5.1M | 1.69% |
| CITADEL ADVISORS LLC | 394,323 | $2.9M | 0.95% |
| RENAISSANCE TECHNOLOGIES LLC | 191,000 | $1.4M | 0.46% |
| TWO SIGMA INVESTMENTS, LP | 46,402 | $341,519 | 0.11% |
| D. E. Shaw & Co., Inc. | 32,397 | $238,442 | 0.08% |
| Point72 Asset Management, L.P. | 28,500 | $209,760 | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.